The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina

American Journal on Addictions

Volumn 20, Issue 5, 2011, Pages 447-455

  Price, Kimber L ^a   Desantis, Stacia M ^a   Simpson, Annie N ^a   Tolliver, Bryan K ^a   McRae Clark, Aimee L ^a   Saladin, Michael E ^a   Baker, Nathaniel L ^a   Wagner, Mark T ^a   Brady, Kathleen T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CALIFORNIA VERBAL LEARNING TEST; COGNITION; DEMOGRAPHY; DRUG DEPENDENCE; FEMALE; GROOVED PEGBOARD TEST; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PACED AUDITORY SERIAL ADDITION TEST; PREDICTION; PSYCHOLOGIC TEST; SHIPLEY INSTITUTE OF LIVING SCALE; SYMBOL DIGIT MODALITIESTEST; TEST OF MEMORY MALINGERING; UNITED STATES; WISCONSIN CARD SORTING TEST;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; COGNITION; COGNITION DISORDERS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; RURAL POPULATION; SEX CHARACTERISTICS; SOUTH CAROLINA;

EID: 80051784238     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00164.x     Document Type: Article

References (68)

1. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No SMA 09-4434). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008.
2. Sekine Y, Iyo M, Ouchi Y, et al,. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001; 158: 1206-1214. (Pubitemid 32717692)
3. Zweben JE, Cohen JB, Christian D, et al,. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004; 13: 181-190. (Pubitemid 38585698)
4. London ED, Simon SL, Berman SM, et al,. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004; 61: 73-84. (Pubitemid 38044643)
5. Kalechstein AD, Newton TF, Longshore D, et al,. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci. 2000; 12: 480-484.
6. Buffenstein A, Heaster J, Ko P,. Chronic psychotic illness from methamphetamine. Am J Psychiatry. 1999; 156: 662.
7. Meredith CW, Jaffe C, Ang-Lee K, et al,. Implications of chronic methamphetamine use: A literature review. Harv Rev Psychiatry. 2005; 13: 141-154. (Pubitemid 40967247)
8. Nordahl TE, Salo R, Leamon M, et al,. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci. 2003; 15: 317-325. (Pubitemid 36999374)
9. Scott JC, Woods SP, Matt GE, et al,. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychol Rev. 2007; 17: 275-297. (Pubitemid 47498174)
10. Chang L, Alicata D, Ernst T, et al,. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007; 102 (Suppl 1): 16-32. (Pubitemid 46328220)
11. Simon SL, Domier C, Carnell J, et al,. Cognitive impairment in individuals currently using methamphetamine. Am J Addict. 2000; 9: 222-231.
12. Monterosso JR, Aron AR, Cordova X, Xu J, London ED,. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 2005; 79: 273-277. (Pubitemid 40942119)
13. Chang L, Ernst T, Speck O, et al,. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res. 2002; 114: 65-79. (Pubitemid 34556681)
14. Hoffman WF, Moore M, Templin R, et al,. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl). 2006; 188: 162-170. (Pubitemid 44371154)
15. Johanson CE, Frey KA, Lundahl LH, et al,. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl). 2006; 185: 327-338.
16. Rippeth JD, Heaton RK, Carey CL, et al,. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004; 10: 1-14. (Pubitemid 38128457)
17. Stoops WW, Tindall MS, Mateyoke-Scrivner A, et al,. Methamphetamine use in nonurban and urban drug court clients. Int J Offender Ther Comp Criminol. 2005; 49: 260-276. (Pubitemid 40632459)
18. Grant KM, Kelley SS, Agrawal S, et al,. Methamphetamine use in rural Midwesterners. Am J Addict. 2007; 16: 79-84. (Pubitemid 46633927)
19. Tolliver BK, McRae-Clark AL, Saladin M, et al,. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Am J Drug Alcohol Abuse. 2010; 36: 106-113.
20. Price KL, Saladin ME, Baker NL, et al,. Extinction of drug cue reactivity in methamphetamine-dependent individuals. Behav Res Ther. 2010; 48: 860-865.
21. Sheehan D, Janavs J, Baker R, et al,. MINI: Mini International Neuropsychiatric Interview. Tampa, FL: University of South Florida Press; 2003.
22. Sobell LC, Sobell MB,. Timeline follow-back: A technique for assessing self-reported ethanol consumption. In:, Allen J, Litten RZ, eds. Measuring Alcohol Consumption: Psychological and Biological Methods. Totowa, NJ: Humana Press; 1992: 41-72.
23. Tombaugh TN., The Test of Memory Malingering. Toronto, Canada: Multi-Health Systems; 1996.
24. Shipley WC,. A self-administering scale for measuring intellectual impairment and deterioration. J Psychol: Interdisciplinary and Applied. 1940; 9: 371-377.
25. Sampson H,. Serial addition as a function of stimulus duration and pacing. Can J Psychol. 1958; 12: 179-183.
26. Sampson H,. Pacing and performance on a serial addition task. Can J Psychol. 1956; 10: 219-225.
27. Smith A., Symbol Digit Modalities Test. Los Angeles: Western Psychological Services; 1982.
28. Smith A,. The symbol-digit modalities test: A neuropsychologic test of learning and other cerebral disorders. In:, Helmuth J, ed. Learning Disorders. Seattle: Special Child Publications; 1968: 83-91.
29. Klove H,. Clinical neuropsychology. In:, Forster FM, ed. The Medical Clinics of North America. New York: Saunders; 1963.
30. Matthews CG, Klove H,. Instruction Manual for the Adult Neuropsychology Test Battery. Madison, WI: University of Wisconsin Medical School; 1964.
31. Delis DC, Kramer JH, Kaplan E, et al,. The California Verbal Learning Test. San Antonio, TX: Psychological Corporation; 1987.
32. Delis DC, Kramer JH, Kaplan E, et al,. California Verbal Learning Test: Second Edition. San Antonio, TX: Psychological Corporation; 2000.
33. Berg EA,. A simple objective test for measuring flexibility of thinking. J Gen Psychol. 1948; 39: 15-22.
34. Grant DA, Berg EA,. A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigltype card sorting problem. J Exp Psychol Anim Behav Process. 1948; 34: 404-411.
35. Strauss E, Sherman EMS, Spreen O,. A Compendium of Neuropsychological Tests, 3rd edn. New York: Oxford University Press; 2006.
36. Chang L, Cloak C, Patterson K, et al,. Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response. Biol Psychiatry. 2005; 57: 967-974. (Pubitemid 40603079)
37. Chang L, Ernst T, Speck O, et al,. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res. 2002; 114: 65-79. (Pubitemid 34556681)
38. Gonzalez R, Rippeth JD, Carey CL, et al,. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend. 2004; 76: 181-190. (Pubitemid 39370814)
39. Gonzalez R, Bechara A, Martin EM,. Executive functions among individuals with methamphetamine or alcohol as drugs of choice: Preliminary observations. J Clin Exp Neuropsychol. 2007; 29: 155-159.
40. Kalechstein AD, Newton TF, Green M,. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci. 2003; 15: 215-220. (Pubitemid 36520342)
41. Kalechstein AD, De la Garza R, 2nd, Newton TF, et al,. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21: 254-258.
42. Hoffman WF, Moore M, Templin R, et al,. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl). 2006; 188: 162-170. (Pubitemid 44371154)
43. McCann UD, Kuwabara H, Kumar A, et al,. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse. 2008; 62: 91-100.
44. Monterosso JR, Aron AR, Cordova X, et al,. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 2005; 79: 273-277. (Pubitemid 40942119)
45. Salo R, Leamon MH, Natsuaki Y, et al,. Findings of preserved implicit attention in methamphetamine dependent subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32: 217-223.
46. Salo R, Nordahl TE, Buonocore MH, et al,. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: A diffusion tensor imaging study. Biol Psychiatry. 2009; 65: 122-128.
47. Salo R, Nordahl TE, Moore C, et al,. A dissociation in attentional control: Evidence from methamphetamine dependence. Biol Psychiatry. 2005; 57: 310-313. (Pubitemid 40187376)
48. Salo R, Nordahl TE, Natsuaki Y, et al,. Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry. 2007; 61: 1272-1280. (Pubitemid 46726259)
49. Sim T, Simon SL, Domier CP, et al,. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology. J Addict Dis. 2002; 21: 75-89. (Pubitemid 35203855)
50. Johanson CE, Frey KA, Lundahl LH, et al,. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl). 2006; 185: 327-338.
51. Newton TF, Kalechstein AD, Hardy DJ, et al,. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol. 2004; 115: 194-198. (Pubitemid 38045614)
52. Salo R, Ursu S, Buonocore MH, et al,. Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: A functional magnetic resonance imaging study. Biol Psychiatry. 2009; 65: 706-709.
53. Simon SL, Domier C, Carnell J, et al,. Cognitive impairment in individuals currently using methamphetamine. Am J Addict. 2000; 9: 222-231.
54. IES. National Center for Education Statistics. Washington DC: US Department of Education; 2007.
55. Toomey R, Lyons MJ, Eisen SA, et al,. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry. 2003; 60: 303-310. (Pubitemid 36307442)
56. Volkow ND, Chang L, Wang GJ, et al,. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci. 2001; 21: 9414-9418. (Pubitemid 33096884)
57. Volkow ND, Chang L, Wang GJ, et al,. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001; 158: 377-382. (Pubitemid 32205193)
58. Aharonovich E, Hasin DS, Brooks AC, et al,. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006; 81: 313-322. (Pubitemid 43152458)
59. Fals-Stewart W, Bates ME,. The neuropsychological test performance of drug-abusing patients: An examination of latent cognitive abilities and associated risk factors. Exp Clin Psychopharmacol. 2003; 11: 34-45. (Pubitemid 36237341)
60. Fals-Stewart W, Schafer J,. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. J Clin Psychol. 1992; 48: 539-543.
61. Kim SJ, Lyoo IK, Hwang J, et al,. Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology. 2005; 30: 1383-1391. (Pubitemid 40848092)
62. Azcoitia I, Sierra A, Garcia-Segura LM,. Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin-like growth factor-I signalling. J Neurosci Res. 1999; 58: 815-822.
63. Culmsee C, Vedder H, Ravati A, et al,. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: Evidence for a receptor-independent antioxidative mechanism. J Cereb Blood Flow Metab. 1999; 19: 1263-1269. (Pubitemid 30176455)
64. Dluzen DE, McDermott JL,. Estrogen, testosterone, and methamphetamine toxicity. Ann N Y Acad Sci. 2006; 1074:282- 294.
65. Gajjar TM, Anderson LI, Dluzen DE,. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm. 2003; 110: 1215-1224. (Pubitemid 37500744)
66. Gomes-da-Silva J, Perez-Rosado A, de Miguel R, et al,. Neonatal methamphetamine in the rat: Evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system. Ann N Y Acad Sci. 2000; 914: 431-438.
67. Heller A, Bubula N, Lew R, et al,. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug. J Pharmacol Exp Ther. 2001; 298: 769-779. (Pubitemid 32673430)
68. Wagner GC, Tekirian TL, Cheo CT,. Sexual differences in sensitivity to methamphetamine toxicity. J Neural Transm Gen Sect. 1993; 93: 67-70. (Pubitemid 23235619)